Products (23 Offers)

Sorted By:

Category Filter

  • Substance
    • AOD 9604
    • Bremelanotide
    • CJC-1295 Injection
    • Cagrilintide
    • Epithalon
    • GHK-CU
    • Insulin-like Growth Factor 1
    • Ipamorelin
    • Long R3 Injection
    • MOTS-c
    • Mazdutide
    • Melanotan
    • Pentadecapeptide
    • Retatrutide
    • Selank
    • Semaglutide
    • Semax Heptapeptide
    • Sermorelin
    • Survodutide
    • Tesamorelin
    • Thymosin beta 4
    • Thymosin beta 4 / Pentadecapeptide
    • Tirzepatide
  • Shipping Location
    • Asia
    • Europe
    • International
    • U.S Domestic
US Domestic & International
TIRZEPATIDE 5mg
Dragon Pharma, Europe

Molecular Formula: C225H348N48O68S2
Molecular Weight:
4813.03 g/mol
Brand:
Dragon Pharma Peptide Line

Dragon Tirzepatide is a novel medication designed for the treatment of type 2 diabetes, and it is currently being investigated for potential applications in weight management. It is classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This dual action harnesses the complementary effects of both incretin hormones to improve glycemic control and support metabolic health.

By enhancing insulin secretion in response to meals, reducing glucagon concentrations, and slowing gastric emptying, Tirzepatide peptide aids in stabilizing blood glucose levels. However, its use requires careful consideration of associated side effects such as nausea, diarrhea, and the potential increased risk of pancreatitis, emphasizing the need for healthcare providers to monitor patients closely during treatment.

View Tirzepatide lab tested

🛻 Free Shipping on orders over $1000

90.00 USD  
US Domestic & International
MAZDUTIDE 10mg
Dragon Pharma, Europe

Molecular Formula: C304H451N79O92S6
Molecular Weight:
6973.52 g/mol
Brand:
Dragon Pharma Peptide Line

Dragon Mazdutide Peptide is a synthetic compound classified as a peptide-based therapeutic agent under investigation for its potential role in metabolic regulation. This peptide functions by targeting specific receptors involved in processes such as glucose metabolism and appetite control, which may position it as a candidate for treating conditions like diabetes or obesity.

Although preclinical and early clinical studies have shown promising results regarding its efficacy and safety, more rigorous research is required to validate its use in broader medical applications. It is crucial to approach emerging therapeutics like Mazdutide peptide with cautious optimism, as long-term effects and potential adverse interactions remain areas of active investigation.

🛻 Free Shipping on orders over $1000

100.00 USD  
US Domestic & International
SURVODUTIDE 10mg
Dragon Pharma, Europe

Dragon Survodutide peptide is an investigational therapeutic agent under development that combines mechanisms targeting both appetite regulation and metabolic processes.

It is categorized as a dual GLP-1 and glucagon receptor agonist, functioning by influencing pathways involved in energy balance and glycemic control. This compound has been studied primarily for its potential applications in managing obesity and related metabolic disorders.

While its efficacy and safety are promising in preliminary trials, further rigorous clinical evaluation is essential to determine its long-term effects and appropriate use cases.

🛻 Free Shipping on orders over $1000

100.00 USD  
AOD 9604 5mg
Dragon Pharma, Europe

Molecular Formula: C78H123N23O23S2
Molecular Weight:
1815.08 g/mol
Brand:
Dragon Pharma Peptide Line

Dragon Peptide AOD9604, also known as AOD9604 peptide, is a modified fragment of human growth hormone (hGH), specifically the hGH fragment 176-191. This peptide contains a di-sulfide bridge, making it a derivative of hGH. AOD9604 was initially developed as a compound to promote lipolysis (fat breakdown) and support fat metabolism.

Research has shown that AOD 9604 stimulates lipolysis while inhibiting lipogenesis, the process through which the body stores fat. Beyond its potential as a fat-burning agent, studies suggest that AOD9604 peptide may provide additional therapeutic benefits, including potential applications in addressing heart disease, osteoarthritis, cartilage repair, and metabolic syndrome.

While offering promising potential, these findings are predominantly based on studies and need to be further evaluated for practical applications.

🛻 Free Shipping on orders over $1000

Out of stock
GHK-CU 10mg
Dragon Pharma, Europe

Molecular Formula: C14H24N6O4Cu
Molecular Weight:
340.89 g/mol
Brand:
Dragon Pharma Peptide Line

Dragon GHK-Cu Peptide, or copper tripeptide, is a natural protein fragment found in human plasma that decreases as we age. It's a widely studied peptide known for its use in skincare and hair care products. GHK-Cu is commonly used in anti-aging creams, wrinkle treatments, after-sun products, skin moisturizers, and hair growth formulas.

This peptide works by delivering copper to the skin, which activates processes that heal wounds and repair tissue. Research also shows that GHK-Cu Peptide can help make skin smoother, thicker, and firmer by boosting collagen production. Additionally, it supports wound healing, encourages new tissue growth, and improves the appearance of aging skin and hair.

Furthermore, GHK-Cu peptide offers protective benefits like reducing inflammation and delivering antioxidant effects.

🛻 Free Shipping on orders over $1000

Out of stock
MOTS-c 10mg
Dragon Pharma, Europe

Molecular Formula: C47H71N13O12S1
Molecular Weight:
1030.23 g/mol
Brand:
Dragon Pharma Peptide Line

Dragon MOTS-c is a mitochondrial-derived peptide (MDP) consisting of 16 amino acids, recognized for its pivotal role in regulating cellular metabolism. Synthesized within the mitochondria, MOTS-c contributes to maintaining metabolic balance by modulating processes such as glucose metabolism, insulin sensitivity, and the cellular response to stress. 

Notably, MOTS-c translocates to the nucleus, where it directly impacts the expression of genes associated with mitochondrial biogenesis and metabolic regulation, particularly under conditions of metabolic stress.

This peptide has been shown to improve exercise capacity and support metabolic homeostasis, with significant potential benefits including reductions in obesity and insulin resistance. Additionally, research highlights MOTS-c's role in mitigating various disease processes, such as osteoporosis, metabolic disorders, and age-related diseases, emphasizing its broader impact on promoting longevity and overall health.

🛻 Free Shipping on orders over $1000

Out of stock
PE 22-28

Molecular Formula: C35H55N11O9
Molecular Weight:
773.8947 g/mol
Brand:
Dragon Pharma Peptide Line

PE-22-28 is a synthetic analog derived from the naturally occurring peptide spadin, which interacts with the TREK-1 potassium channel. TREK-1 is predominantly localized in areas of the brain associated with mood regulation, memory processing, and learning capabilities. Current research into PE-22-28 is exploring its potential therapeutic roles, including its antidepressant properties, enhancement of cognitive function, support in stroke recovery, and applications in combating neurodegenerative disorders such as Alzheimer's disease.

Out of stock
1 2 >
Filter Checked

Add in Cart - Product(s)

Close Button
Empty

Total Cost: